Open original FDA record ↗Recall record
- FDA identifier
- Z-2559-2014
- Company in FDA record
- Nanosphere, Inc.
- FDA classification date
- Aug 28, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Nanosphere has recieved reports related to an unacceptable increase in initial no-call rate when performing the Verigene CYP2C19 Nucleic Acid Test (2C19), which has been confirmed through internal testing.
Source facts
- Action
- Nanosphere sent an Field Notification Letter dated March 18, 2014, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The letters included instructions for customers to: 1) discontinue use of the affected products, 2) discard the affected product, and 3) complete and return the attached for to obtain free-of-charge replacement kits. Customers with any questions about this recall should contact their Nanosphere technical support representative at 1 888 837-4436. .
- Initiated
- 2014-03-18
- Root cause
- Under Investigation by firm
- Terminated
- 2015-07-02
- Distribution
- Worldwide Distribution - US including the states of AL, CA, MD, ND, NJ, OK and TX., and internationally to Bulgaria, China and New Zealand.
- Recall number
- Z-2559-2014
- Recall status
- Terminated
- CDRH record ID
- 128490
- FDA classified
- 2014-08-28
- Recall event number
- 68710